Search Results - "ENGBER, Thomas M."
-
1
Small Molecule SARM1 Inhibitors Recapitulate the SARM1−/− Phenotype and Allow Recovery of a Metastable Pool of Axons Fated to Degenerate
Published in Cell reports (Cambridge) (05-01-2021)“…Axonal degeneration is responsible for disease progression and accumulation of disability in many neurodegenerative conditions. The axonal degenerative process…”
Get full text
Journal Article -
2
cADPR is a gene dosage-sensitive biomarker of SARM1 activity in healthy, compromised, and degenerating axons
Published in Experimental neurology (01-07-2020)“…SARM1 is the central executioner of pathological axon degeneration, promoting axonal demise in response to axotomy, traumatic brain injury, and neurotoxic…”
Get full text
Journal Article -
3
Studies to Assess the Utility of Serum Neurofilament Light Chain as a Biomarker in Chemotherapy-Induced Peripheral Neuropathy
Published in Cancers (23-08-2023)“…Chemotherapy-induced peripheral neuropathy (CIPN) is one of the most common and disabling dose-limiting toxicities of chemotherapy. We report here the results…”
Get full text
Journal Article -
4
Synthesis of alkyne derivatives of a novel triazolopyrazine as A2A adenosine receptor antagonists
Published in Bioorganic & medicinal chemistry letters (01-02-2005)Get full text
Journal Article -
5
Novel Bicyclic Piperazine Derivatives of Triazolotriazine and Triazolopyrimidines as Highly Potent and Selective Adenosine A2A Receptor Antagonists
Published in Journal of medicinal chemistry (02-12-2004)“…A series of bicyclic piperazine derivatives of triazolotriazine and triazolopyrimidines was synthesized. Some of these analogues show high affinity and…”
Get full text
Journal Article -
6
Effect of combined treatment with methylprednisolone and soluble Nogo-66 receptor after rat spinal cord injury
Published in The European journal of neuroscience (01-08-2005)“…Methylprednisolone (MP) is a synthetic glucocorticoid used for the treatment of spinal cord injury (SCI). Soluble Nogo‐66 receptor (NgR) ectodomain is a novel…”
Get full text
Journal Article -
7
Therapeutic efficacy of sonic hedgehog protein in experimental diabetic neuropathy
Published in The Journal of clinical investigation (01-02-2003)“…Hedgehog proteins modulate development and patterning of the embryonic nervous system. As expression of desert hedgehog and the hedgehog receptor, patched-1,…”
Get full text
Journal Article -
8
D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons
Published in Science (American Association for the Advancement of Science) (07-12-1990)“…The striatum, which is the major component of the basal ganglia in the brain, is regulated in part by dopaminergic input from the substantia nigra. Severe…”
Get full text
Journal Article -
9
Motor fluctuations in levodopa treated parkinsonian rats: relation to lesion extent and treatment duration
Published in Brain research (31-10-1994)“…The pathogenesis of the motor fluctuations that complicate levodopa treatment of most parkinsonian patients remains uncertain. To evaluate the contribution of…”
Get more information
Journal Article -
10
Long-acting forms of Sonic hedgehog with improved pharmacokinetic and pharmacodynamic properties are efficacious in a nerve injury model
Published in Journal of pharmaceutical sciences (01-02-2002)“…The therapeutic effects of the Sonic hedgehog (Shh) have been difficult to evaluate because of its relatively short serum half-life. To address this issue…”
Get more information
Journal Article -
11
Differential patterns of regional c-Fos induction in the rat brain by amphetamine and the novel wakefulness-promoting agent modafinil
Published in Neuroscience letters (30-01-1998)“…We examined the neuronal targets in the rat brain for the novel wakefulness-promoting agent modafinil and for amphetamine using c-Fos immunohistochemistry…”
Get full text
Journal Article -
12
NMDA receptor blockade reverses motor response alterations induced by levodopa
Published in Neuroreport (20-12-1994)“…Motor fluctuations that ultimately complicate the response of most parkinsonian patients to levodopa therapy might represent a form of behavioral or neuronal…”
Get more information
Journal Article -
13
Motor response complications and the function of striatal efferent systems
Published in Neurology (01-12-1993)“…Motor response complications eventually appear in most patients with advanced Parkinsonʼs disease being treated with levodopa. The interval between onset of…”
Get full text
Journal Article -
14
First Synthesis of Piperazine-derived [1,2,4]Triazolo[1,5-a]pyrazine as an Adenosine A2A Receptor Antagonist
Published in Heterocycles (01-10-2005)Get full text
Journal Article -
15
Substance P increases release of acetylcholine in the dorsal striatum of freely moving rats
Published in Brain research (01-10-1993)“…Little is known about the role that neuropeptides such as substance P play in cell-to-cell interactions in the striatum. The effect of locally perfused…”
Get more information
Journal Article -
16
GABAA and GABAB receptors differentially regulate striatal acetylcholine release in vivo
Published in Neuroscience letters (01-10-1993)“…Microdialysis was used to study the effects of selective GABAergic agents on striatal acetylcholine (ACh) release in awake, freely moving rats. Local perfusion…”
Get more information
Journal Article -
17
Identification of insulin-like growth factor binding protein-2 as a biochemical surrogate marker for the in vivo effects of recombinant human insulin-like growth factor-1 in mice
Published in The Journal of pharmacology and experimental therapeutics (01-04-1997)“…Recent studies indicate that a daily s.c. injection of 1 mg/kg of recombinant human insulin-like growth factor-1 (rhIGF-1) for 17 days is efficacious in…”
Get more information
Journal Article -
18
Region‐Specific Targets of p42/p44MAPK Signaling in Rat Brain
Published in Journal of neurochemistry (01-02-1998)“…: In vitro studies indicate that p42/p44MAPK phosphorylate both nuclear and cytoplasmic proteins. However, the functional targets of p42/p44MAPK activation in…”
Get full text
Journal Article -
19
Controls for Lesions of the Nigrostriatal Dopamine System
Published in Science (American Association for the Advancement of Science) (19-07-1991)Get full text
Journal Article -
20
Synthesis of alkyne derivatives of a novel triazolopyrazine as A 2A adenosine receptor antagonists
Published in Bioorganic & medicinal chemistry letters (01-02-2005)“…[Display omitted] A novel [1,2,4]triazolo[1,5- a]pyrazine core was synthesized and coupled with terminal acetylenes. The structure–activity relationship of the…”
Get full text
Journal Article